Kewan T, Alomari M, Khazaaleh S, Covut F, Olayan M. Hand-foot Syndrome Secondary to Low-dose Docetaxel in a Breast Cancer Patient.
Cureus 2019;
11:e4400. [PMID:
31245190 PMCID:
PMC6559678 DOI:
10.7759/cureus.4400]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/25/2019] [Accepted: 04/04/2019] [Indexed: 11/05/2022] Open
Abstract
Docetaxel-induced hand-foot syndrome (HFS) at low doses is a very rare side effect that usually occurs in a dose-dependent manner. HFS can be managed with conservative measures and may need chemotherapy discontinuation. In this report we present a case of HFS in a breast cancer patient after one dose of docetaxel.
Collapse